Doris Ogresta Kordej

Dr. Doris Ogresta Kordej

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2022 in Journal of Clinical and Translational Hepatology
Verified
Journal Article
Open access
DKDoris Ogresta Kordej
Doris Ogresta Kordej
Anna MrzljakAnna Mrzljak
Anna Mrzljak
Maja Cigrovski BerkovicMaja Cigrovski Berkovic
Maja Cigrovski Berkovic
IBInes Bilić-Čurčić
Ines Bilić-Čurčić
SSSanja Stojsavljevic Shapeski
Sanja Stojsavljevic Shapeski
LJLucija Virović Jukić
Lucija Virović Jukić
Non-alcoholic fatty liver disease (NAFLD) is closely related to insulin resistance, type 2 diabetes mellitus and obesity. It is considered a multisystem disease and there is a strong association with cardiovascular disease and arterial hypertension, which interfere with changes in the coagulation system. Coagulation disorders are common in patients with hepatic impairment and are dependent on the degree of liver damage. Through a review of the literature, we consider and discuss possible disorders in the coagulation cascade and fibrinolysis, endothelial dysfunction and platelet abnormalities in patients with NAFLD.

11 December 2024
Verified
Book Chapter
Open access
PDF file
VTVedran Tomasic
Vedran Tomasic
ABAlen Bišćanin
Alen Bišćanin
DKDominik Kralj
Dominik Kralj
PĆPetra Ćaćić
Petra Ćaćić
DKDoris Ogresta Kordej
Doris Ogresta Kordej
The global incidence and age-standardized prevalence rate of ulcerative colitis (UC) is increasing worldwide. It is a debilitating and lifelong inflammatory disease affecting both pediatric and adult patients. Thus, it is important to focus on modern treat-to-target approach, based on a tight control of the disease with close monitoring through interval assessments and modification of the treatment. Endoscopy remains the key method for UC assessment, but recent guidelines focus on implementation of non-invasive methods for UC diagnosis and management such as biomarkers (C-reactive protein, fecal calprotectin, and fecal lactofferin) and imaging methods (intestinal ultrasound). We summarize the diagnostic performance of non-invasive tests and present current evidence-based non-invasive strategy recommendations for UC monitoring.

12 July 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
ABAlen Bišćanin
Alen Bišćanin
LPLeon Palac
Leon Palac
ZDZdravko Dorosulić
Zdravko Dorosulić
DKDominik Kralj
Dominik Kralj
PĆPetra Ćaćić
Petra Ćaćić
VTVedran Tomasic
Vedran Tomasic
Background/Objectives: Inflammatory bowel disease (IBD) is a chronic gastrointestinal disorder marked by relapsing episodes of gastrointestinal inflammation, potentially causing severe symptoms. These unpredictable acute episodes, paired with chronic disabilities, such as fatigue and malabsorption, and extensive pharmacological and surgical treatments, can severely impact patients’ quality of life. This study aimed to assess which aspects of the patients’ lives IBD impacts, and how IBD patients perceive their disease. Methods: All IBD patients who had an appointment in our tertiary centre from 10 October 2022 to 21 February 2023, were invited to complete anonymous questionnaires. The questionnaires used were IBDQ-32, WPAI, and IBD Disk, all designed specifically to assess the IBD patients’ quality of life. Results: The questionnaires were completed by a total of 159 participants, 51% of whom were males, 47.9% who had UC, and 49.4% who had been or were currently treated with biologics. There was no statistically significant difference in the answers from patients with CD compared to UC, as well as those treated with conventional therapies compared to those with advanced options. Most of them considered their health to be good, but only a few (12.8%) claimed, with absolute certainty, that their health was at the level of healthy individuals, and only 13 (8.3%) claimed their health was excellent. A total of 95 (60.1%) participants expressed at least minor limitations when performing strenuous activities, but lighter forms of activities were not affected as much by the disease. A significant portion (48.7%) of the participants believed they were exposed to more stress than others, and their current pharmacological therapy was the cause of fear in 26.5%. A total of 119 (75.3%) participants believed that the disease affected their lives at least mildly during remission. Conclusions: Our study showed that IBD patients have diminished quality of life, not only in the periods of active disease but also during clinical remission. The decline in quality of life was not solely attributed to physical symptoms, as previously thought. Other factors, such as mental health issues, were found to impact quality of life as well. We firmly believe that restoring quality of life should be emphasised in guidelines as one of the most important therapeutic goals.

1 January 2019 in Trends in Medicine
Verified
Journal Article
Open access
SPSanja Popović-Grle
Sanja Popović-Grle
VDVišnja Dukić
Višnja Dukić
JŠJosipa Škugor
Josipa Škugor
DODominik Oroz
Dominik Oroz
DKDoris Ogresta Kordej
Doris Ogresta Kordej
OA Text is an independent open-access scientific publisher showcases innovative research and ideas aimed at improving health by linking research and practice to the benefit of society.

15 March 2022 in Turkish Journal of Gastroenterology
Verified
Journal Article
Closed access
DHDavor Hrabar
Davor Hrabar
PĆPetra Ćaćić
Petra Ćaćić
ABAlen Bišćanin
Alen Bišćanin
VTVedran Tomasic
Vedran Tomasic
DKDominik Kralj
Dominik Kralj
TBToni Babarović
Toni Babarović
Background: Severe acute respiratory syndrome coronavirus 2 pandemic is affecting public health systems and mental health significantly. Patients with inflammatory bowel disease are witnessing vigorous organizational changes in inflammatory bowel disease centers and experiencing all psychosocial effects of the crisis. We conducted a single-center cross-sectional study in order to assess inflammatory bowel disease patients’ concerns, behavior, and satisfaction with provided healthcare during severe acute respiratory syndrome coronavirus 2 pandemic. Methods: All inflammatory bowel disease patients treated in our center from April 1 to June 1, 2020, were invited to fulfill an anonymous online questionnaire. Results: A total of 132 participants have completed the questionnaire, 63.2% were female, 57.9% had Crohn’s disease (CD) During the first wave of the pandemic, 74.2% of participants perceived themselves as a high-risk group for acquiring coronavirus disease 2019 only because they suffered from inflammatory bowel disease, and 66.2% thought inflammatory bowel disease medications make them more susceptible to coronavirus disease 2019. This especially concerned patients treated with biologics (B = 2.068, P < .01). Females were more stressed (B = −1.451, P < .01) and concerned (B = −1.488, P < .01) about the pandemic, and they also reported more potential benefits from professional psychological help (B = −2.664, P = .02). Six patients (5.3%) discontinued inflammatory bowel disease therapy on their own initiative. Seventy-eight (68.4%) patients were completely satisfied and 14 (12.3%) were partially satisfied with the quality of healthcare provided in our inflammatory bowel disease center. Conclusion: Female inflammatory bowel disease patients tend to be more emotionally vulnerable during severe acute respiratory syndrome coronavirus 2 pandemic. Although psychological support should be continuously available to all inflammatory bowel disease patients, female gender may warrant special attention. Providing patients with adequate and early information during pandemic probably leads to better compliance and higher satisfaction. Cite this article as: Hrabar D, Cacic P, Biscanin A, et al. IBD patients’ perception of severe acute respiratory syndrome coronavirus 2 pandemic and satisfaction with provided healthcare: A cross-sectional study. Turk J Gastroenterol. 2022;33(3):190-195.

27 April 2020 in Southeastern European medical journal
Verified
Journal Article
Open access
PDF file
IŠIVAN ŠVAGELJ
IVAN ŠVAGELJ
IVIvan Vlahović
Ivan Vlahović
DKDoris Ogresta Kordej
Doris Ogresta Kordej
DBDražen Belina
Dražen Belina
ZKZdenko Kovač
Zdenko Kovač
Aim: The most important risk factors for a Stanford type A acute aortic dissection (AAD) include arterial hypertension and connective tissue disorders, while numerous studies have identified meteorology factors, such as environmental temperature also play an important role. The aim of this study is to explore the relationship between environmental temperature and the frequency of AAD surgically threated over a 12-year period at a Croatian university hospital. Methods: This is a retrospective, monocenter observational study conducted at the University Hospital Centre Zagreb. The study includes 134 patients who were threated surgically for Stanford type A AAD between January 2001 and December 2012. Temperature categories (low, moderate and high) were based on the calculated monthly average environmental temperature and standard deviation given from official daily environmental temperatures for the respective period. Results: The results show a higher frequency of AAD in days of low temperature compared to days of moderate temperature or high temperature. The frequency of days with AAD was somewhat higher in moderate than high temperature category, but the difference is not statistically significant. The relative frequency of AAD for low, moderate and high temperature categories were 4.55, 2.96 and 1.93, respectively. Conclusion: Environmental temperature drop induces stressful adaptive body response, including an additional hemodynamic load and increase in arterial blood pressure, strong enough to trigger the AAD-etiopathogenesis. Furthermore, our findings indicate that body response to environmental heat may differ from a response to reduced environmental temperature, due to observed small number of events in days of high temperature.